3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
9
Breast Neoplasms
6
Lymphoma, B-Cell, Marginal Zone
4
Barrett Esophagus
4
Lymphoma, Large B-Cell, Diffuse
3
Inflammation
3
Head and Neck Neoplasms
3
Zollinger-Ellison Syndrome
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Lymphoma
2
Colorectal Neoplasms
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Stomach Ulcer
1
Solid Tumours
1
Solid Tumor
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Prostate Cancer Patients
1
Precancerous Gastric Lesions
1
Pharmacokinetics of MDV3100
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Interventions
Docetaxel
277
Prednisone
236
enzalutamide
175
Leuprolide
172
Radiotherapy
164
Abiraterone Acetate
153
Magnetic Resonance Spectroscopy
147
bicalutamide
137
Goserelin
134
Androgen Antagonists
111
Radiosurgery
101
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
100
apalutamide
78
abiraterone
75
gallium 68 PSMA-11
74
Specimen Handling
67
Gonadotropin-Releasing Hormone
58
darolutamide
56
Radiation
56
Triptorelin Pamoate
53
cabazitaxel
49
Zoledronic Acid
49
pembrolizumab
48
Radiotherapy, Intensity-Modulated
47
Flutamide
47
Brachytherapy
47
luprolide acetate gel depot
46
Standard of Care
45
Carboplatin
44
Estramustine
43
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Neoplasms
×
Omeprazole
×
Clear all
NCT04337580
2026-04-13
FASN
Wake Forest University Health Sciences
Phase 2
Recruiting
50 enrolled